Hjem
  • E-postole.norheim@uib.no
  • Telefon+47 55 58 61 45
  • Besøksadresse
    OVERLEGE DANIELSSENS HUS (4. etasje)
    Årstadveien 21
    5009 Bergen
    Rom 
    444
  • Postadresse
    Postboks 7804
    5020 Bergen

H-index: 53 (Web of Science)

H-index: 58 (Scopus)

Publications listed in Pubmed

Profile on Google Scholar

Books and reports (not listed in Pubmed).

Adler, Matthew D. & Norheim, Ole F. (eds.). Prioritarianism in Practice. Cambridge University Press; 2022.

Cookson, Richard; Griffin, Susan; Norheim, Ole F.; Culyer, Anthony (eds). Distributional cost-effectiveness analysis: quantifying health equity impacts and trade-offs. Oxford University Press; 2020.

Norheim, Ole F.; Emanuel, Ezekiel J.; Millum, Joseph (eds). Global Health Priority-Setting: Beyond Cost-Effectiveness. Oxford University Press; 2020.

Eyal N, Hurst S, Norheim OF, Wikler D, (eds). Inequalities in health: concepts, measures, and ethics. New York: Oxford University Press; 2013.

Norheim OF (Chair), Allgott B, Aschim B, Førde R, Gjul GK, Gundersen T, Kakad M, Kjellevold A, Kvinnsland S, Melberg HO, Moen A, Mæland Ø, Olsen JA, Sjøli S. Åpent og rettferdig - prioriteringer i helsetjenesten [Open and fair - priorities in the Norwegian healthcare services – in Norwegian]. Norges Offentlige Utredninger, NOU 14: 12.

Ottersen T, Norheim OF (Chair), Bona M Chitah BM, Cookson R, Daniels N, Defaye FB et al. Making fair choices on the path to universal health coverage. Final report of the WHO Consultative Group on Equity and Universal Health Coverage. Geneva: World Health Organization 2014.  

 

Vitenskapelig artikkel
  • Vis forfatter(e) (2022). The magnitude and perceived reasons for childhood cancer treatment abandonment in Ethiopia: from health care providers’ perspective. BMC Health Services Research.
  • Vis forfatter(e) (2022). The global temperature-related mortality impact of earlier decarbonization for the Australian health sector and economy: A modelling study. PLOS ONE. 10 sider.
  • Vis forfatter(e) (2022). Public participation: healthcare rationing in the newspaper media. BMC Health Services Research.
  • Vis forfatter(e) (2022). Effect of kangaroo mother care initiated in community settings on financial risk protection of low-income households: a randomised controlled trial in Haryana, India. BMJ Global Health. 1-9.
  • Vis forfatter(e) (2022). Appraising Drugs Based on Cost-effectiveness and Severity of Disease in Norwegian Drug Coverage Decisions. JAMA Network Open. 9 sider.
  • Vis forfatter(e) (2021). Toward Universal Health Coverage in the post-COVID-19 era. Nature Medicine. Nature Medicine.
  • Vis forfatter(e) (2021). Reducing regional health inequality: a sub-national distributional cost-effectiveness analysis of community-based treatment of childhood pneumonia in Ethiopia. International Journal for Equity in Health. 1-10.
  • Vis forfatter(e) (2021). Public health priority setting: A case for priority to the worse off in well-being during the COVID-19 pandemic. Etikk i praksis. 5-15.
  • Vis forfatter(e) (2021). Priority setting and net zero healthcare: how much health can a tonne of carbon buy? The BMJ.
  • Vis forfatter(e) (2021). Prioritizing health-sector interventions for noncommunicable diseases and injuries in low- And lower-middle income countries: national ncdi poverty commissions. Global Health: Science and Practice (GHSP). 626-639.
  • Vis forfatter(e) (2021). Precision medicine and the principle of equal treatment: a conjoint analysis. BMC Medical Ethics. 9 sider.
  • Vis forfatter(e) (2021). On the Ethics of Vaccine Nationalism: The Case for the Fair Priority for Residents Framework. Ethics and International Affairs.
  • Vis forfatter(e) (2021). Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries. Scientific Reports.
  • Vis forfatter(e) (2021). Maintaining neglected tropical disease programmes during pandemics. Bulletin of the World Health Organization. 473-474.
  • Vis forfatter(e) (2021). Is universal health coverage affordable? Estimated costs and fiscal space analysis for the Ethiopian Essential Health Services Package . Health Systems & Reform.
  • Vis forfatter(e) (2021). Health equity impact of community-initiated kangaroo mother care: a randomized controlled trial. International Journal for Equity in Health. 8 sider.
  • Vis forfatter(e) (2021). Generalised cost-effectiveness analysis of 159 health interventions for the Ethiopian essential health service package. Cost Effectiveness and Resource Allocation.
  • Vis forfatter(e) (2021). Estimating and Comparing Health and Financial Risk Protection Outcomes in Economic Evaluations. Value in Health. 238-246.
  • Vis forfatter(e) (2021). Equity in Public Health Spending in Ethiopia: Benefit Incidence Analysis. Health Policy and Planning. i4-i13.
  • Vis forfatter(e) (2021). Cost-Effectiveness of Saxagliptin Compared With Glibenclamide as a Second-Line Therapy Added to Metformin for Type 2 Diabetes Mellitus in Ethiopia. Medical Decision Making Policy & Practice. 12 sider.
  • Vis forfatter(e) (2021). Contextualization of cost-effectiveness evidence from literature for 382 health interventions for the Ethiopian essential health services package revision. Cost Effectiveness and Resource Allocation. 10 sider.
  • Vis forfatter(e) (2021). Climate change and health in Ethiopia: To what extent have the health dimensions of climate change been integrated into the Climate-Resilient Green Economy? World Medical & Health Policy (WMHP). 293-312.
  • Vis forfatter(e) (2020). What next after GDP-based cost-effectiveness thresholds? Gates Open Research.
  • Vis forfatter(e) (2020). Revision of the Ethiopian Essential Health Service Package: An Explication of the Process and Methods Used. Health Systems & Reform. 12 sider.
  • Vis forfatter(e) (2020). Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17. The Lancet Global Health. 1162-1185.
  • Vis forfatter(e) (2020). An ethical framework for global vaccine allocation. Science. 1309-1312.
  • Vis forfatter(e) (2019). Priority setting on the path to UHC: Time for stronger institutions and stronger health systems: Response to recent commentaries. International Journal of Health Policy and Management. 511-513.
  • Vis forfatter(e) (2019). Financial risk protection at the bedside: How Ethiopian physicians try to minimize out-of-pocket health expenditures. PLOS ONE. 1-16.
  • Vis forfatter(e) (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 1789-1858.
  • Vis forfatter(e) (2018). Allocating external financing for health: A discrete choice experiment of stakeholder preferences. Health Policy and Planning. i24-i30.
  • Vis forfatter(e) (2017). When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework. BMJ Open. 9 sider.
  • Vis forfatter(e) (2017). Using cost-effectiveness analysis to address health equity concerns. Value in Health. 206-212.
  • Vis forfatter(e) (2017). Universal health coverage, priority setting, and the human right to health. The Lancet. 2 sider.
  • Vis forfatter(e) (2017). Three case studies in making fair choices on the path to universal health coverage. Health and Human Rights: An International Journal. 11-22.
  • Vis forfatter(e) (2017). The disvalue of death in the global burden of disease. Journal of Medical Ethics. 192-198.
  • Vis forfatter(e) (2017). Progressive realisation of universal health coverage: What are the required processes and evidence? BMJ Global Health.
  • Vis forfatter(e) (2017). Out-of-pocket expenditures for prevention and treatment of cardiovascular disease in general and specialised cardiac hospitals in Addis Ababa, Ethiopia: a cross-sectional cohort study. BMJ Global Health.
  • Vis forfatter(e) (2017). Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. The Lancet. 1423-1459.
  • Vis forfatter(e) (2017). Making fair choices on the path to universal health coverage: Applying principles to difficult cases. Health Systems & Reform. 301-312.
  • Vis forfatter(e) (2017). Is the sustainable development goal target for financial risk protection in health realistic? BMJ Global Health.
  • Vis forfatter(e) (2017). Increased risk of peripartum perinatal mortality in unplanned births outside an institution: a retrospective population-based study. American Journal of Obstetrics and Gynecology. 210.e1-210.e12.
  • Vis forfatter(e) (2017). Impact of community-initiated Kangaroo Mother Care on survival of low birth weight infants: Study protocol for a randomized controlled trial. Trials. 1-10.
  • Vis forfatter(e) (2017). Household expenditures on pneumonia and diarrhea treatment in Ethiopia: a facility-based study. BMJ Global Health.
  • Vis forfatter(e) (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet. 231-266.
  • Vis forfatter(e) (2017). Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 1084-1150.
  • Vis forfatter(e) (2017). Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 1260-1344.
  • Vis forfatter(e) (2017). Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 1345-1422.
  • Vis forfatter(e) (2017). Global Health Inequality: Comparing Inequality-Adjusted Life Expectancy over Time. Public Health Ethics. 188-211.
  • Vis forfatter(e) (2017). Etikkarbeid i lavinntektsland: Etiopia som eksempel (Ethics capacity building in low income countries: Ethiopia as a case). Tidsskrift for Den norske legeforening.
  • Vis forfatter(e) (2017). Economic losses and burden of disease by medical conditions in Norway. Health Policy. 691-698.
  • Vis forfatter(e) (2017). Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health Loss. PharmacoEconomics (Auckland). 965-974.
  • Vis forfatter(e) (2017). Costs and expected gain in lifetime health from intensive care versus general ward care of 30,712 individual patients: A distribution-weighted cost-effectiveness analysis. Critical Care. 1-13.
  • Vis forfatter(e) (2017). Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania. PLOS ONE. 1-20.
  • Vis forfatter(e) (2016). Three case studies in making fair choices on the path to universal health coverage. Health and Human Rights: An International Journal. 11-22.
  • Vis forfatter(e) (2016). Response to our critics. Health Economics, Policy and Law. 103-111.
  • Vis forfatter(e) (2016). Prevention and treatment of cardiovascular disease in Ethiopia: A cost-effectiveness analysis. Cost Effectiveness and Resource Allocation. 1-14.
  • Vis forfatter(e) (2016). Norwegian priority setting in practice - An analysis of waiting time patterns across medical disciplines. International Journal of Health Policy and Management. 373-378.
  • Vis forfatter(e) (2016). Making fair choices on the path to universal health coverage: a précis. Health Economics, Policy and Law. 71-77.
  • Vis forfatter(e) (2016). Inequalities in utilization of maternal and child health services in Ethiopia: The role of primary health care. BMC Health Services Research. 8 sider.
  • Vis forfatter(e) (2016). Impact of a peer-counseling intervention on breastfeeding practices in different socioeconomic strata: results from the equity analysis of the PROMISE-EBF trial in Uganda. Global health action.
  • Vis forfatter(e) (2016). Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 1725-1774.
  • Vis forfatter(e) (2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 1459-1544.
  • Vis forfatter(e) (2016). Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 1775-1812.
  • Vis forfatter(e) (2016). Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 1545-1602.
  • Vis forfatter(e) (2016). Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 1603-1658.
  • Vis forfatter(e) (2016). Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 1659-1724.
  • Vis forfatter(e) (2016). Ethical priority setting for universal health coverage: challenges in deciding upon fair distribution of health services. BMC Medicine.
  • Vis forfatter(e) (2016). Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015. The Lancet HIV. e361-e387.
  • Vis forfatter(e) (2016). Equity impact analysis of medical approaches to cardiovascular diseases prevention in Tanzania. Social Science and Medicine. 208-217.
  • Vis forfatter(e) (2016). Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: A Markov modelling study. BMC Health Services Research.
  • Vis forfatter(e) (2016). Budget impact analysis of using dihydroartemisinin–piperaquine to treat uncomplicated malaria in children in Tanzania. PharmacoEconomics (Auckland). 303-314.
  • Vis forfatter(e) (2016). Assessing the burden of medical impoverishment by cause: A systematic breakdown by disease in Ethiopia. BMC Medicine. 1-11.
  • Vis forfatter(e) (2016). A new proposal for priority setting in Norway: Open and fair. Health Policy. 246-251.
  • Vis forfatter(e) (2015). Unexplained health inequality - Is it unfair? International Journal for Equity in Health.
  • Vis forfatter(e) (2015). Towards universal health coverage for reproductive health services in Ethiopia: Two policy recommendations. International Journal for Equity in Health.
  • Vis forfatter(e) (2015). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 743-800.
  • Vis forfatter(e) (2015). Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. The Lancet. 2145-2191.
  • Vis forfatter(e) (2015). Economic cost of primary prevention of cardiovascular diseases in Tanzania. Health Policy and Planning. 875-884.
  • Vis forfatter(e) (2015). Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania. Cost Effectiveness and Resource Allocation. 1-12.
  • Vis forfatter(e) (2015). Avoiding 40% of the premature deaths in each country, 2010-30: Review of national mortality trends to help quantify the UN Sustainable Development Goal for health. The Lancet. 239-252.
  • Vis forfatter(e) (2014). Work participation among the morbidly obese seeking bariatric surgery: an exploratory study from Norway. Obesity Surgery. 271-278.
  • Vis forfatter(e) (2014). Valuing vaccines using value of statistical life measures. Vaccine. 5065-5070.
  • Vis forfatter(e) (2014). Understanding inequalities in child health in Ethiopia: Health achievements are improving in the period 2000-2011. PLOS ONE.
  • Vis forfatter(e) (2014). The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania. PLOS ONE. 10 sider.
  • Vis forfatter(e) (2014). Taking equality seriously: Applying human rights frameworks to priority setting in health. Human Rights Quarterly. 296-324.
  • Vis forfatter(e) (2014). Maternal and neonatal mortality in south-west ethiopia: Estimates and socio-economic inequality. PLOS ONE.
  • Vis forfatter(e) (2014). Making use of equity sensitive QALYs: A case study on identifying the worse off across diseases. Cost Effectiveness and Resource Allocation.
  • Vis forfatter(e) (2014). Making fair choices on the path to universal health coverage: A précis. Health Economics, Policy and Law. 71-77.
  • Vis forfatter(e) (2014). Lifetime QALY prioritarianism in priority setting: Quantification of the inherent trade-off. Cost Effectiveness and Resource Allocation.
  • Vis forfatter(e) (2014). Implementation of transcatheter aortic valve insertion (TAVI) in clinical practice: An ethical analysis. Clinical Ethics. 96-103.
  • Vis forfatter(e) (2014). Health rights litigation and access to medicines: Priority classification of successful cases from Costa Rica’s constitutional chamber of the supreme court. Health and Human Rights: An International Journal. 47-61.
  • Vis forfatter(e) (2014). Guidance on priority setting in health care (GPS-Health): The inclusion of equity criteria not captured by cost-effectiveness analysis. Cost Effectiveness and Resource Allocation. 8 sider.
  • Vis forfatter(e) (2014). Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 980-1004.
  • Vis forfatter(e) (2014). Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990—2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 1005-1070.
  • Vis forfatter(e) (2014). Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 117-171.
  • Vis forfatter(e) (2014). Disease control priorities for neglected tropical diseases: lessons from priority ranking based on the quality of evidence, cost effectiveness, severity of disease, catastrophic health expenditures, and loss of productivity. Developing World Bioethics. 132-141.
  • Vis forfatter(e) (2014). Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania. Malaria Journal.
  • Vis forfatter(e) (2014). Availability and access in modern obstetric care: a retrospective population-based study. BJOG: An International Journal of Obstetrics and Gynaecology. 290-299.
  • Vis forfatter(e) (2014). Annual rates of decline in child, maternal, HIV, and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2013: An assessment of the feasibility of post-2015 goals. The Lancet Global Health. e698-e709.
  • Vis forfatter(e) (2014). A three-stage approach to measuring health inequalities and inequities . International Journal for Equity in Health.
  • Vis forfatter(e) (2014). A grand convergence in mortality is possible: comment on Global Health 2035. International Journal of Health Policy and Management.
  • Vis forfatter(e) (2013). Health inequalities in Ethiopia: modeling inequalities in length of life within and between population groups. International Journal for Equity in Health. 8 sider.
  • Vis forfatter(e) (2013). Balancing efficiency, equity and feasibility of HIV treatment in South Africa – development of programmatic guidance. Cost Effectiveness and Resource Allocation.
  • Vis forfatter(e) (2012). When you can't have the cake and eat it too. A study of medical doctors' priorities in complex choice situations. Social Science and Medicine. 1964-1973.
  • Vis forfatter(e) (2012). Prioritizing child health interventions in Ethiopia: modeling impact on child mortality, life expectancy and inequality in age at death. PLOS ONE. 9 sider.
  • Vis forfatter(e) (2012). Medisinske metodevurderinger (HTA) for bedre prioriteringer av helsetjenester. Michael Quarterly. 174-182.
  • Vis forfatter(e) (2012). Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis. BMC Cardiovascular Disorders. 12 sider.
  • Vis forfatter(e) (2012). Challenges to fair decision-making processes in the context of health care services: a qualitative assessment from Tanzania. International Journal for Equity in Health. 12 sider.
  • Vis forfatter(e) (2012). Addressing inequity to achieve the maternal and child health millennium development goals: looking beyond averages. BMC Public Health. 7 sider.
  • Vis forfatter(e) (2012). A universal preference for equality in health? Reasons to reconsider properties of applied social welfare functions. Social Science and Medicine. 1836-1843.
  • Vis forfatter(e) (2011). Problems With Prioritization: Exploring Ethical Solutions to Inequalities in HIV Care. American Journal of Bioethics. 32-40.
  • Vis forfatter(e) (2011). MAPPING OUT STRUCTURAL FEATURES IN CLINICAL CARE CALLING FOR ETHICAL SENSITIVITY: A THEORETICAL APPROACH TO PROMOTE ETHICAL COMPETENCE IN HEALTHCARE PERSONNEL AND CLINICAL ETHICAL SUPPORT SERVICES (CESS). Bioethics. 394-402.
  • Vis forfatter(e) (2011). Incorporating concerns for equal lifetime health in evaluations of public health programs. Social Science and Medicine. 1711-1716.
  • Vis forfatter(e) (2011). HIV priorities and health distributions in a rural region in Tanzania: a qualitative study. Journal of Medical Ethics. 221-226.
  • Vis forfatter(e) (2011). Equity implications of coverage and use of insecticide treated nets distributed for free or with co-payment in two districts in Tanzania: A cross-sectional comparative household survey. International Journal for Equity in Health. 8 sider.
  • Vis forfatter(e) (2010). Global helseprioritering. Aftenposten (morgenutg. : trykt utg.).
  • Vis forfatter(e) (2010). Gini Impact Analysis: Measuring Pure Health Inequity Before and After Interventions. Public Health Ethics. 282-292.
  • Vis forfatter(e) (2010). Further benefits by early start of HIV treatment in low income countries: survival estimates of early versus deferred antiretroviral therapy. AIDS research and therapy.
  • Vis forfatter(e) (2010). End-of-life decisions as bedside rationing. An ethical analysis of life support restrictions in an Indian neonatal unit. Journal of Medical Ethics. 473-478.
  • Vis forfatter(e) (2010). Disability compensation and responsibility. Politics, Philosophy and Economics. 411-427.
  • Vis forfatter(e) (2010). Disability compensation and responsibility. Politics, Philosophy and Economics. 411-427.
  • Vis forfatter(e) (2009). The ideal of equal health revisited: definitions and measures of inequity in health should be better integrated with theories of distributive justice. International Journal for Equity in Health. 9 sider.
  • Vis forfatter(e) (2009). Is the selection of patients for anti-retroviral treatment in Uganda fair? A qualitative study. Health Policy. 33-42.
  • Vis forfatter(e) (2009). Impact of Ethics and Economics on End-of-Life Decisions in an Indian Neonatal Unit. Pediatrics. E322-E328.
  • Vis forfatter(e) (2009). Høykostnadsmedisin - mangler vi åpne og legitime prosedyrer for prioritering? Tidsskrift for Den norske legeforening. 17-20.
  • Vis forfatter(e) (2009). Fairness and accountability for reasonableness. Do the views of priority setting decision makers differ across health systems and levels of decision making? Social Science and Medicine. 766-773.
  • Vis forfatter(e) (2009). Eliciting people's preferences for the distribution of health: A procedure for a more precise estimation of distributional weights. Journal of Health Economics. 570-577.
  • Vis forfatter(e) (2009). A note on Brock: prioritarianism, egalitarianism and the distribution of life years. Journal of Medical Ethics. 565-569.
  • Vis forfatter(e) (2008). Variation in practice: A questionnaire survey of how congruence in attitudes between doctors and patients influences referral decisions. Medical decision making. 262-268.
  • Vis forfatter(e) (2008). Seguro Popular - en helsereform for de fattigste. Tidsskrift for Den norske legeforening. 1860-1863.
  • Vis forfatter(e) (2008). National HIV treatment guidelines in Tanzania and Ethiopia: are they legitimate rationing tools? Journal of Medical Ethics. 478-483.
  • Vis forfatter(e) (2008). Genomics and equal opportunity ethics. Journal of Medical Ethics. 361-364.
  • Vis forfatter(e) (2008). Genomics and equal opportunity ethics. Journal of Medical Ethics. 361-364.
  • Vis forfatter(e) (2008). Etiske valg ved medisinsk nytteløs behandling. Tidsskrift for Den norske legeforening. 2185-2189.
  • Vis forfatter(e) (2008). Distribution matters: Equity considerations among health planners in Tanzania. Health Policy. 218-227.
  • Vis forfatter(e) (2008). Clinical priority setting. BMJ. British Medical Journal.
  • Vis forfatter(e) (2008). "What lies beneath it all?" - an interview study of GPs' attitudes to the use of guidelines. BMC Health Services Research.
  • Vis forfatter(e) (2007). Priority setting at the micro-, meso- and macro-levels in Canada, Norway and Uganda. Health Policy. 78-94.
  • Vis forfatter(e) (2007). Physicians' use of guidelines and attitudes to withholding and withdrawing treatment for extremely premature neonates in Norway. Acta Paediatrica. 825-829.
  • Vis forfatter(e) (2007). Livsforlengende behandling - analyse av to kasuistikker. Tidsskrift for Den norske legeforening. 878-881.
  • Vis forfatter(e) (2007). Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country - the case of Tanzania. Cost Effectiveness and Resource Allocation.
  • Vis forfatter(e) (2007). Combining evidence and values in priority setting: testing the balance sheet method in a low-income country. BMC Health Services Research.
  • Vis forfatter(e) (2006). Responsibility, fairness and rationing in health care. Health Policy. 312-319.
  • Vis forfatter(e) (2006). Responsibility, fairness and rationing in health care. Health Policy. 312-319.
  • Vis forfatter(e) (2006). My job is to keep him alive, but what about his brother and sister? How Indian doctors experience ethical dilemmas in neonatal medicine. Developing World Bioethics. 23-32.
  • Vis forfatter(e) (2005). “Saying no is no easy matter”. A qualitative study of competing concerns in rationing decisions in general practice. BMC Health Services Research. 19 sider.
  • Vis forfatter(e) (2005). Rights to specialized health care in Norway: a normative perspective. Journal of Law, Medicine & Ethics (JLME). 641-649.
  • Vis forfatter(e) (2005). Responsibility in health care: a liberal egalitarian approach. Journal of Medical Ethics. 476-480.
  • Vis forfatter(e) (2005). Responsibility in health care: a liberal egalitarian approach. Journal of Medical Ethics. 476-480.
  • Vis forfatter(e) (2005). Hva hindrer åpenhet om prioriteringer? Tidsskrift for velferdsforskning. 73-80.
  • Vis forfatter(e) (2005). Human resources for emergency obstetric care in northern Tanzania: distribution of quantity or quality? Human Resources for Health. 12 sider.
  • Vis forfatter(e) (2005). Availability, distribution and use of emergency obstetric care in northern Tanzania. Health Policy and Planning. 167-175.
  • Vis forfatter(e) (2004). Is cost-effectiveness analysis preferred to severity of disease as the main guiding principle in priority setting in resource poor settings? The case of Uganda. Cost Effectiveness and Resource Allocation.
  • Vis forfatter(e) (2004). Hvordan påvirker fastlegeordningen legens skjønnsmessige<BR/>avgjørelser? Tidsskrift for velferdsforskning. 33-47.
  • Vis forfatter(e) (2004). Criteria for priority-setting in health care in Uganda: exploration of stakeholders' values. Bulletin of the World Health Organization. 172-179.
  • Vis forfatter(e) (2004). Complicated deliveries, critical care and quality in emergency obstetric care in Northern Tanzania. International Journal of Gynecology & Obstetrics. 98-108.
  • Vis forfatter(e) (2003). Using burden of disease information for health planning in developing countries: the experience from Uganda. Social Science and Medicine. 2433-2441.
  • Vis forfatter(e) (2003). The relationship between prevention of mother to child transmission of HIV and stakeholder decision making in Uganda: Implications for health policy. Health Policy. 199-211.
  • Vis forfatter(e) (2003). Public participation in health planning and priority setting at the district level in Uganda. Health Policy and Planning. 205-213.
  • Vis forfatter(e) (2003). Introduction of the Patient-list System in General Practice: Changes in Norwegian Physicians’ Perception of their Gatekeeper Role. Scandinavian Journal of Primary Health Care. 209-213.
  • Vis forfatter(e) (2002). Whose priorities count? Comparison of community-identified health problems and Burden-of-Disease-assessed health priorities in a district in Uganda. Health Expectations. 55-62.
  • Vis forfatter(e) (2001). New guidelines for priority setting in Norway: Are they applicable for the evaluation of new health care services? Health Policy. 65-79.
  • Vis forfatter(e) (2001). Kunnskap må kombineres med verdier ved beslutninger under usikkerhet. Tidsskrift for Den norske legeforening. 1387-1390.
  • Vis forfatter(e) (2000). Limiting access to allogeneic bone marrow transplantation in five European countries: what can we learn about implicit rationing? Health Policy. 149-156.
  • Vis forfatter(e) (2000). Limiting access to allogeneic bone marrow transplantation in five European countries: what can we learn about implicit rationing? Health Policy. 149-156.
  • Vis forfatter(e) (2000). Legen - den enøyde samaritan? Tidsskrift for Den norske legeforening. 1207-1209.
  • Vis forfatter(e) (2000). Legen - den enøyde samaritan? Tidsskrift for Den norske legeforening. 1207-1209.
  • Vis forfatter(e) (2000). Alendronat også til kvinner uten etablert osteoporose? Tidsskrift for Den norske legeforening. 1347-1351.
  • Vis forfatter(e) (2000). Alendronat også til kvinner uten etablert osteoporose? Tidsskrift for Den norske legeforening. 1347-1351.
  • Vis forfatter(e) (1999). Access to Health Care in the Scandinavian Countries: Ethical Aspects. Health Care Analysis. 321-330.
Vitenskapelig foredrag
  • Vis forfatter(e) (2018). Prioritering og folkehelse.
  • Vis forfatter(e) (2018). Prioritering mellom folkehelsetiltak.
  • Vis forfatter(e) (2018). Inkluderende evaluering av folkehelsetiltak.
  • Vis forfatter(e) (2008). Burden of disease among the poor in Tanzania. Rights, priorities and implementation.
  • Vis forfatter(e) (2007). ART in Africa does not lead to improved equity in health.
  • Vis forfatter(e) (2007). ART in Africa does not lead to improved equity in health.
  • Vis forfatter(e) (2003). Introduction of the patient-list system in general practice: Changes in Norwegian physicians’ perception of their gatekeeper role.
  • Vis forfatter(e) (2002). The cost-effectiveness of selected interventions targeting major source of burden of disease in Tanzania.
Vitenskapelig antologi/Konferanseserie
  • Vis forfatter(e) (2019). Global Health Priority-Setting: Beyond Cost-Effectiveness . Oxford University Press.
  • Vis forfatter(e) (2017). Cancer Biomarkers: Ethics, Economics and Society. Megaloceros Press.
  • Vis forfatter(e) (2013). Inequalities in health: concepts, measures, and ethics. Oxford University Press.
  • Vis forfatter(e) (2013). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing hiv infection. Recommendations for a public health approach. World Health Organization.
Sammendrag/abstract
  • Vis forfatter(e) (2021). How much health can a ton of carbon buy? Tropical medicine & international health.
  • Vis forfatter(e) (2013). Availability and access in modern obstetric care: a retrospective population-based cohort study. BJOG: An International Journal of Obstetrics and Gynaecology. 412-413.
  • Vis forfatter(e) (2009). INCORPORATING EQUITY IN COST-EFFECTIVENESS ANALYSIS: A SYSTEMATIC REVIEW. Value in Health. A230-A230.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2023). Criteria for the procedural fairness of health financing decisions: a scoping review. Health Policy and Planning. i13-i35.
  • Vis forfatter(e) (2023). Country readiness and prerequisites for successful design and transition to implementation of essential packages of health services: Experience from six countries. BMJ Global Health.
  • Vis forfatter(e) (2022). Addressing the Impact of Noncommunicable Diseases and Injuries (NCDIs) in Ethiopia: Findings and Recommendations from the Ethiopia NCDI Commission. Ethiopian Journal of Health Sciences. 161-180.
  • Vis forfatter(e) (2021). What are the obligations of pharmaceutical companies in a global health emergency? The Lancet. 1015-1020.
  • Vis forfatter(e) (2021). Institutional and behaviour-change interventions to support COVID-19 public health measures: A review by the Lancet Commission Task Force on public health measures to suppress the pandemic. International Health. 399-409.
  • Vis forfatter(e) (2020). The burden of household out-of-pocket health expenditures in Ethiopia: estimates from a nationally representative survey (2015–16). Health Policy and Planning. 1003-1010.
  • Vis forfatter(e) (2020). Protecting essential health services in low-income and middle-income countries and humanitarian settings while responding to the COVID-19 pandemic. BMJ Global Health. 1-9.
  • Vis forfatter(e) (2019). Health system modelling research: towards a whole-health-system perspective for identifying good value for money investments in health system strengthening. BMJ Global Health. 1-5.
  • Vis forfatter(e) (2018). How can MCDA tools improve priority setting? Four critical questions. Cost Effectiveness and Resource Allocation. 1-3.
  • Vis forfatter(e) (2018). High-quality health systems in the Sustainable Development Goals era: time for a revolution. The Lancet Global Health. e1196-e1252.
  • Vis forfatter(e) (2017). Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition. The Lancet. 1108-1120.
  • Vis forfatter(e) (2015). Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2287-2323.
  • Vis forfatter(e) (2015). A survey of Ethiopian physicians’ experiences of bedside rationing: extensive resource scarcity, tough decisions and adverse consequences. BMC Health Services Research. 1-8.
  • Vis forfatter(e) (2012). Comparative effectiveness of antihypertensive medication of primary prevention of cardiovascular disease: Systematic review and multiple treatments meta-analysis. BMC Medicine.
  • Vis forfatter(e) (2012). Can cost-effictiveness analysis integrate concerns for equity? Systematic review. International Journal of Technology Assessment in Health Care. 125-132.

Se fullstendig oversikt over publikasjoner i CRIStin.

Ole Frithjof Norheimer lege og professor i medisinsk etikk ved Institutt for global helse og samfunnsmedisin ved Universitetet i Bergen. Leder for Bergen Senter for etikk og prioritering (BCEPS), finansiert av UiB, Trond Mohn Stiftelse, Norad og NFR. Adjunct professor ved Department of Global Health and Population, Harvard T.H. Chan School of Public Health. Medlem av Det Norske Videnskaps-Akademi fra 2021.  

Norheims forskningsinteresser er etikk og prioritering innen helse, nasjonalt og globalt. Han jobber både akademisk og praktisk med hvordan man kan utforme helsesystemer som gir effektiv og rettferdig ressursutnyttelse. Han har ledet det regjeringsoppnevnte utvalget for prioritering i helsetjenesten (Norheimutvalget) som la fram sin rapport Åpen og rettferdig – prioriteringer i helsetjenesten (NOU 2014: 12) og Verdens helseorganisasjons rådgivende gruppe for likhet og universelle helsetjenester som i 2014 la fram rapporten Making Fair Choices on the Path to Universal Health Coverage (WHO 2014). Tidligere leder av Bioteknologirådet (2019 – 2023).

Han har publisert mer enn 200 fagfellevurderte artikler i tidsskrift som Lancet, Science, BMJ, Bulletin of WHO, Health Policy and Planning, og Journal of Medical Ethics.

 

Kompetansefelt